niacinamide has been researched along with Leukemia, Myelomonocytic, Chronic in 3 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Leukemia, Myelomonocytic, Chronic: A myelodysplastic-myeloproliferative disease characterized by monocytosis, increased monocytes in the bone marrow, variable degrees of dysplasia, but an absence of immature granulocytes in the blood.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gu, J | 1 |
Wang, Z | 1 |
Xiao, M | 1 |
Mao, X | 1 |
Zhu, L | 1 |
Wang, Y | 1 |
Huang, W | 1 |
von Bubnoff, N | 1 |
Rummelt, C | 1 |
Menzel, H | 1 |
Sigl, M | 1 |
Peschel, C | 1 |
Duyster, J | 1 |
Kosmider, O | 1 |
Chapuis, N | 1 |
Kaltenbach, S | 1 |
Coriat, R | 1 |
Boudou Rouquette, P | 1 |
Willems, L | 1 |
Chesnais, V | 1 |
Radford-Weiss, I | 1 |
Bardet, V | 1 |
Mayeux, P | 1 |
Tamburini, J | 1 |
Fontenay, M | 1 |
Bouscary, D | 1 |
3 other studies available for niacinamide and Leukemia, Myelomonocytic, Chronic
Article | Year |
---|---|
Chronic myelomonocytic leukemia with double-mutations in DNMT3A and FLT3-ITD treated with decitabine and sorafenib.
Topics: Azacitidine; Decitabine; DNA (Cytosine-5-)-Methyltransferases; DNA Methyltransferase 3A; fms-Like Ty | 2017 |
Identification of a secondary FLT3/A848P mutation in a patient with FLT3-ITD-positive blast phase CMML and response to sunitinib and sorafenib.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Female; fms-Like Tyrosine K | 2010 |
Sustained leukemia-free state and molecular response to sorafenib in a patient with chronic myelomonocytic leukemia in transformation driven by homozygous FLT3-ITD malignant hematopoiesis.
Topics: Antineoplastic Agents; fms-Like Tyrosine Kinase 3; Hematopoiesis; Humans; Leukemia, Myelomonocytic, | 2013 |